FDA Approves New HIV Treatment Edurant (rilpivirine)
Links shared publicly online about this topic.
- 278total visits
FDA Approves New HIV Treatment Edurant (rilpivirine)
View full resource at drugs.com
Tags: Infection, HIV, STD, FDA
Most Recently Shared on May 21, 2011 at 1:05 am By:
FDA Approves New HIV Treatment Edurant (rilpivirine) - http://bit.ly/jlzzjz
Approval of Complera: emtricitabine/rilpivirine/tenofovir DF fixed dose combination
fda.gov — “FDA approval of Approval of Complera, a new emtricitabine/rilpivirine/tenofovir DFfixed dose combination product for treatment of HIV” View full resource at fda.gov
Most Recently Shared on August 11, 2011 at 3:02 pm By:
Trish D'Antonio Health Professional
HIV and AIDS Activities Approval of Complera: emtricitabine/rilpivirine/tenofovir DF fixed dose combination: http://t.co/BVRnb2W
Once-Daily Single-Tablet Complera For HIV-1 Infection Approved By FDA - QualityPoint Technologies
qualitypointtech.net — “The US FDA has approved Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate), a once-a-day single tablet for patients with HIV-1 infection who are new to treatment (treatment-naïve patients), makers and marketers Gilead Sciences Inc. announced today. Complera contains three antiretroviral drugs in one tablet: Truvada - a Gilead medication, a fixed-dose combination of two medications, emtricitabine and tenofovir disoproxil fumarate. Approved by the FDA in August 2004...” View full resource at qualitypointtech.net
Most Recently Shared on August 11, 2011 at 1:45 am By:
Once-Daily Single-Tablet Complera For HIV-1 Infection Approved By FDA: The US FDA has approved Complera (emtricita... http://bit.ly/ozFQu6
Once-Daily Single-Tablet Complera For HIV-1 Infection Approved By FDA
medicalnewstoday.com — “The US FDA has approved Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate), a once-a-day single tablet for patients with HIV-1 infection who are new to treatment (treatment-naïve” View full resource at medicalnewstoday.com
Most Recently Shared on August 11, 2011 at 12:05 am By:
MNT Drug Approvals Health News
Once-Daily Single-Tablet Complera For HIV-1 Infection Approved By FDA http://mnt.to/3YS9 #regulatory
U.S. Food and Drug Administration Approves Gilead Sciences' Complera, a New Complete Once-Daily, Single-Tablet Regimen for HIV-1 Infection in Treatment-Naïve Adults
drugs.com — “Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) is used to treat HIV infection. Includes Complera side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 10, 2011 at 11:27 pm By:
FDA Approves Complera, a Once-Daily, Single-Tablet Regimen for HIV-1 Infection - http://bit.ly/nXmNLg
Untreated HIV Patients Have New Drug Option (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- The recently approved anti-HIV drug rilpivirine (Edurant) is a new option for people starting treatment for the virus, according to investigators on two randomized controlled trials.” View full resource at qualitypointtech.net
Most Recently Shared on July 14, 2011 at 10:45 pm By:
Untreated HIV Patients Have New Drug Option (CME/CE): (MedPage Today) -- The recently approved anti-HIV drug rilpi... http://bit.ly/poDS7z
Medical News: Untreated HIV Patients Have New Drug Option - in Clinical Context, HIV/AIDS from MedPage Today
medpagetoday.com — “The recently approved anti-HIV drug rilpivirine (Edurant) is a new option for people starting treatment for the virus, according to investigators on two randomized controlled trials.” View full resource at medpagetoday.com
Most Recently Shared on July 14, 2011 at 10:44 pm By:
Recently approved HIV drug Edurant provides alternative to Sustiva: http://bit.ly/q0JAwg
FDA Approves New HIV Treatment
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Edurant (rilpivirine) in combination with other antiretroviral drugs for the treatment of HIV-1 infection in adults who have never taken HIV therapy” View full resource at medicalnewstoday.com
Most Recently Shared on May 26, 2011 at 8:05 am By:
MNT Drug Approvals Health News
FDA Approves New HIV Treatment http://mnt.to/3WmX #regulatory
Rilpivirine (Edurant) - The Body
thebody.com — “What Is Rilpivirine? Rilpivirine is a drug used as part of antiretroviral therapy (ART). It is also called Edurant. It is manufactured by Tibotec ...” View full resource at thebody.com
Most Recently Shared on May 25, 2011 at 10:01 pm By:
New fact sheet on Edurant (rilpivirine), the latest HIV drug approved by the FDA: http://bit.ly/lxavFs #hiv #aids #nnrtis
FDA Approves New HIV Drug Edurant
webmd.com — “The FDA has approved Edurant (rilpivirine) for use in anti-HIV drug cocktails. Edurant is as effective as the popular Sustiva and is in the same NNRTI class of antiretroviral drugs.” View full resource at webmd.com
Most Recently Shared on May 24, 2011 at 4:06 pm By:
FDA Approves New HIV Drug Edurant: The FDA has approved Edurant (rilpivirine) for use in anti-HIV drug cocktails... http://bit.ly/iUYTTI
FDA Approves EDURANT™ (rilpivirine) For Use In Treatment-Naïve Adults With HIV-1: The US Food and Drug Admi... http://bit.ly/is8JI2
medworm.com — “FDA Approves EDURANTâ„¢ (rilpivirine) For Use In Treatment-Naïve Adults With HIV-1: The US Food and Drug Admi... http://bit.ly/is8JI2” View full resource at medworm.com
Most Recently Shared on May 21, 2011 at 9:41 pm By:
FDA Approves EDURANT™ (rilpivirine) For Use In Treatment-Naïve Adults With HIV-1: The US Food and Drug Admi... http://bit.ly/is8JI2
FDA Approves EDURANT™ (rilpivirine) For Use In Treatment-Naïve Adults With HIV-1 - QualityPoint Technologies
qualitypointtech.net — “The US Food and Drug Administration (FDA) approved EDURANTTM (rilpivirine) tablets for use in combination with other antiretroviral agents (ARVs) in the treatment of human immunodeficiency virus type 1 (HIV-1) in adults who have never taken HIV therapy (treatment naïve). EDURANT (pronounced ee' dur ant) was developed as TMC278 (rilpivirine) by Tibotec Pharmaceuticals and is a non-nucleoside reverse transcriptase inhibitor, or NNRTI...” View full resource at qualitypointtech.net
Most Recently Shared on May 21, 2011 at 9:45 am By:
FDA Approves EDURANT™ (rilpivirine) For Use In Treatment-Naïve Adults With HIV-1: The US Food and Drug Admini... http://bit.ly/mpJUNZ
Edurant receives FDA approval for treatment of HIV-1 infection
news-medical.net — “The U.S. Food and Drug Administration today approved Edurant (rilpivirine) in combination with other antiretroviral drugs for the treatment of HIV-1 infection in adults who have never taken HIV therapy (treatment-naive).” View full resource at news-medical.net
Most Recently Shared on May 21, 2011 at 8:06 am By:
HIV/AIDS News: Edurant receives FDA approval for treatment of HIV-1 infection: The U.S. Food and Drug Administra... http://bit.ly/iScGC8
FDA Approves New HIV Treatment Edurant (rilpivirine)
drugs.com — “Edurant (rilpivirine) is used to treat HIV-1 infection. Includes Edurant side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 21, 2011 at 1:04 am By:
Drugs and Devices OW OW Health
FDA Approves New HIV Treatment Edurant (rilpivirine): May 20, 2011 -- The U.S. Food and Drug Administratio... http://bit.ly/lP7KHQ #drug
Edurant a New HIV Treatment Approved by FDA
disabled-world.com — “Edurant is used in combination with other antiretroviral drugs for the treatment of HIV 1 infection in adults” View full resource at disabled-world.com
Most Recently Shared on May 20, 2011 at 10:43 pm By:
Disabled World Health Advocate and Health News
Edurant a New HIV Treatment Approved by FDA http://ff.im/-DOiFz
Advertisement
